drugset / Trial / NCT04452006
A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478
RandomizedParallel-groupQuadruple-blindOther
Summary
A study in healthy subjects to investigate the safety and tolerability of ACT-541478 as well as what ACT-541478 does to the body and the way the body takes up, distributes, and gets rid of of ACT-541478
Timeline
- Start
- 2020-07-20
- Primary completion
- 2021-04-20
- Completion
- 2021-04-20
Outcome
Outcome not reported
Stopped: “Based on interim analysis, the Sponsor decided to terminate the study prematurely.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACT-541478 | Unknown | 10 mg | Oral |
| Subject | ACT-541478 | Unknown | 30 mg | Oral |
| Subject | ACT-541478 | Unknown | 100 mg | Oral |
| Subject | ACT-541478 | Unknown | 300 mg | Oral |
| Subject | ACT-541478 | Unknown | 1000 mg | Oral |
Indications
No indication recorded.